These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 9580589

  • 1. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus.
    Selley DE, Liu Q, Childers SR.
    J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589
    [Abstract] [Full Text] [Related]

  • 2. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR, Nahorski SR.
    Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
    [Abstract] [Full Text] [Related]

  • 3. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.
    Selley DE, Sim LJ, Xiao R, Liu Q, Childers SR.
    Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350
    [Abstract] [Full Text] [Related]

  • 4. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.
    Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1121-7. PubMed ID: 8819494
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.
    Alt A, Mansour A, Akil H, Medzihradsky F, Traynor JR, Woods JH.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):282-8. PubMed ID: 9655870
    [Abstract] [Full Text] [Related]

  • 6. Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus.
    Selley DE, Cao CC, Liu Q, Childers SR.
    Br J Pharmacol; 2000 Jul; 130(5):987-96. PubMed ID: 10882382
    [Abstract] [Full Text] [Related]

  • 7. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H, Wang X, Wang J, Rothman RB.
    Synapse; 2004 Jun 01; 52(3):209-17. PubMed ID: 15065220
    [Abstract] [Full Text] [Related]

  • 8. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
    Martin TJ, Sim LJ, Selley DE, deMontis MG, Childers SR.
    Synapse; 1997 Nov 01; 27(3):177-82. PubMed ID: 9329153
    [Abstract] [Full Text] [Related]

  • 9. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
    Tian WN, Duzic E, Lanier SM, Deth RC.
    Mol Pharmacol; 1994 Mar 01; 45(3):524-31. PubMed ID: 8145737
    [Abstract] [Full Text] [Related]

  • 10. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):676-84. PubMed ID: 9262330
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 01; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec 01; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Separation of binding affinity and intrinsic activity of the potent mu-opioid 14-methoxymetopon.
    Mahurter L, Garceau C, Marino J, Schmidhammer H, Tóth G, Pasternak GW.
    J Pharmacol Exp Ther; 2006 Oct 01; 319(1):247-53. PubMed ID: 16801454
    [Abstract] [Full Text] [Related]

  • 18. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ.
    Mol Pharmacol; 1999 Mar 01; 55(3):564-74. PubMed ID: 10051542
    [Abstract] [Full Text] [Related]

  • 19. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.
    Sim LJ, Selley DE, Childers SR.
    Proc Natl Acad Sci U S A; 1995 Aug 01; 92(16):7242-6. PubMed ID: 7638174
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.